ArticleCancer immunology research2022

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy.

Hiroaki Wakiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.